hydralazine has been researched along with Cell Transformation, Neoplastic in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrade, FO | 1 |
Nguyen, NM | 1 |
Warri, A | 1 |
Hilakivi-Clarke, L | 1 |
Queisser, N | 1 |
Amann, K | 1 |
Hey, V | 1 |
Habib, SL | 1 |
Schupp, N | 1 |
2 other studies available for hydralazine and Cell Transformation, Neoplastic
Article | Year |
---|---|
Reversal of increased mammary tumorigenesis by valproic acid and hydralazine in offspring of dams fed high fat diet during pregnancy.
Topics: Animals; Cell Transformation, Neoplastic; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; Diet, | 2019 |
Blood pressure has only minor influence on aldosterone-induced oxidative stress and DNA damage in vivo.
Topics: Aldosterone; Animals; Apoptosis; Blood Pressure; Cell Transformation, Neoplastic; Cells, Cultured; C | 2013 |